899 results on '"Lisotti, A."'
Search Results
402. Performance of the forward-view echoendoscope for pancreaticobiliary examination in patients with status post-upper gastrointestinal surgery
403. Role of endoscopy in the conservative management of biliary complications after deceased donor liver transplantation
404. Berberine and its metabolites: Relationship between physicochemical properties and plasma levels after administration to human subjects
405. Guidewire stent cannulation and sphincterotome-assisted extraction of proximally migrated biliary plastic stent
406. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: A prospective study
407. Tu1265 Mediterranean Diet (MD) Efficacy in Patients With Slow Transit Constipation (STC)
408. Su1672 Extracorporeal Shock Wave Lithotripsy for Difficult Common Bile Duct Stones: Comparison Between Two Different Lithotripters in a Large Cohort of Patients
409. Berberine and Its Metabolites: Relationship between Physicochemical Properties and Plasma Levels after Administration to Human Subjects
410. OC.19.4 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR DIFFICULT COMMON BILE DUCT STONES: COMPARISON BETWEEN SECOND AND THIRD-GENERATION LITHOTRIPTERS IN A LARGE COHORT OF PATIENTS
411. 1275 SERUM CHENODEOXYCHOLIC ACID, BMI AND TG ARE INDEPENDENTLY RELATED TO INSULIN-RESISTANCE IN BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING PROSPECTIVE STUDY
412. 171 INDOCYANINE GREEN AS A PREDICTOR OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN A PROSPECTIVE COHORT STUDY OF PATIENTS WITH CHRONIC LIVER DISEASE
413. Su1672 Extracorporeal Shock Wave Lithotripsy for Difficult Common Bile Duct Stones: Comparison Between Two Different Lithotripters in a Large Cohort of Patients
414. Tu1265 Mediterranean Diet (MD) Efficacy in Patients With Slow Transit Constipation (STC)
415. OC.19.4 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR DIFFICULT COMMON BILE DUCT STONES: COMPARISON BETWEEN SECOND AND THIRD-GENERATION LITHOTRIPTERS IN A LARGE COHORT OF PATIENTS
416. Chronic NSAIDs Therapy and Upper Gastrointestinal Tract – Mechanism of Injury, Mucosal Defense, Risk Factors for Complication Development and Clinical Management
417. 654 A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY
418. SERUM BILE ACIDS IN PHYSIOLOGICAL PREGNANCY: COMPARISON WITH NON PREGNANT WOMEN
419. The NANOLAB Project: Educational Nanoscience at High School
420. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis
421. High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy
422. Su2037 Effects of a Fermented Milk Containing Kluyveromyces Marxianus B0399 and Bifidobacterium Lactis BB12 in Patients With Irritable Bowel Syndrome: A New Effective Agent
423. Mo1888 Mediterranean Diet Efficacy in Patients With Functional Dyspepsia
424. Educational pathways through nanoscience: nitinol as a paradigmatic smart material
425. 691 SERUM FGF19 LEVELS ARE INDEPENDENTLY RELATED TO BMI IN HEALTHY BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING STUDY
426. 211 INDOCYANINE GREEN CLEARANCE (ICG) AS A PREDICTOR OF 2-YEARS CLINICAL DECOMPENSATION AND MORTALITY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS
427. P.18.22 SERUM FGF19 LEVELS ARE INDEPENDENTLY RELATED TO BMI IN HEALTHY BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING STUDY
428. P.11.17 INDOCYANINE GREEN CLEARANCE (ICG) AS A PREDICTOR OF CLINICAL DECOMPENSATION AND MORTALITY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS
429. Su2037 Effects of a Fermented Milk Containing Kluyveromyces Marxianus B0399 and Bifidobacterium Lactis BB12 in Patients With Irritable Bowel Syndrome: A New Effective Agent
430. Mo1888 Mediterranean Diet Efficacy in Patients With Functional Dyspepsia
431. 211 INDOCYANINE GREEN CLEARANCE (ICG) AS A PREDICTOR OF 2-YEARS CLINICAL DECOMPENSATION AND MORTALITY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS
432. P.18.22 SERUM FGF19 LEVELS ARE INDEPENDENTLY RELATED TO BMI IN HEALTHY BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING STUDY
433. P.11.17 INDOCYANINE GREEN CLEARANCE (ICG) AS A PREDICTOR OF CLINICAL DECOMPENSATION AND MORTALITY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS
434. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience
435. Severe acute autoimmune hepatitis after natalizumab treatment
436. 1275 SERUM CHENODEOXYCHOLIC ACID, BMI AND TG ARE INDEPENDENTLY RELATED TO INSULIN-RESISTANCE IN BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING PROSPECTIVE STUDY
437. P.14.8 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR DIFFICULT BILE DUCT STONES: COMPARISON BETWEEN TWO DIFFERENT LITHOTRIPTERS
438. P.04.3 SERUM CHENODEOXYCHOLIC ACID, BMI AND TG, ARE INDEPENDENTLY RELATED TO INSULIN-RESISTANCE IN BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING PROSPECTIVE STUDY
439. P.19.13 AUTOIMMUNE GASTRITIS ASSOCIATES WITH DUODENAL LYMPHOCYTOSIS
440. P.15.17 TELBIVUDINE TREATMENT FOR FULMINANT HBV HEPATITIS
441. High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-On
442. Indocyanine Green as a Predictor of Clinically Significant Portal Hypertension in a Prospective Cohort Study of Patients With Chronic Liver Disease
443. Long-Term Treatment With Natural Alpha-IFN in Hepatitis C Recurrence After OLT
444. Indocyanine Green Clearance as a Marker of Decompensation and Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
445. P.1.17: INDOCYANINE GREEN AS A PREDICTOR OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN A PROSPECTIVE COHORT STUDY OF PATIENTS WITH CHRONIC LIVER DISEASE
446. 953 INDOCYANINE GREEN CLEARANCE AS A MARKER OF DECOMPENSATION AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS
447. P.1.79: INDOCYANINE GREEN CLEARANCE AS A MARKER OF DECOMPENSATION AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS
448. 171 INDOCYANINE GREEN AS A PREDICTOR OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN A PROSPECTIVE COHORT STUDY OF PATIENTS WITH CHRONIC LIVER DISEASE
449. F-13 Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease
450. P.04.3 SERUM CHENODEOXYCHOLIC ACID, BMI AND TG, ARE INDEPENDENTLY RELATED TO INSULIN-RESISTANCE IN BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING PROSPECTIVE STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.